171 related articles for article (PubMed ID: 32938226)
1. Liquiritigenin decreases tumorigenesis by inhibiting DNMT activity and increasing BRCA1 transcriptional activity in triple-negative breast cancer.
Liang F; Zhang H; Gao H; Cheng D; Zhang N; Du J; Yue J; Du P; Zhao B; Yin L
Exp Biol Med (Maywood); 2021 Feb; 246(4):459-466. PubMed ID: 32938226
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic Regulation of CDH1 Is Altered after HOXB7-Silencing in MDA-MB-468 Triple-Negative Breast Cancer Cells.
Paço A; Leitão-Castro J; Freitas R
Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34680970
[TBL] [Abstract][Full Text] [Related]
3. Curcumin induces re‑expression of BRCA1 and suppression of γ synuclein by modulating DNA promoter methylation in breast cancer cell lines.
Al-Yousef N; Shinwari Z; Al-Shahrani B; Al-Showimi M; Al-Moghrabi N
Oncol Rep; 2020 Mar; 43(3):827-838. PubMed ID: 32020216
[TBL] [Abstract][Full Text] [Related]
4. Methyl CpG binding protein MBD2 has a regulatory role on the BRCA1 gene expression and its modulation by resveratrol in ER+, PR+ & triple-negative breast cancer cells.
Sahu RK; Tandon S; Singh S; Das BC; Hedau ST
BMC Cancer; 2024 May; 24(1):566. PubMed ID: 38711004
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol enhances the sensitivity of FL118 in triple-negative breast cancer cell lines via suppressing epithelial to mesenchymal transition.
Yar Saglam AS; Kayhan H; Alp E; Onen HI
Mol Biol Rep; 2021 Jan; 48(1):475-489. PubMed ID: 33389483
[TBL] [Abstract][Full Text] [Related]
6. Agonists and knockdown of estrogen receptor β differentially affect invasion of triple-negative breast cancer cells in vitro.
Schüler-Toprak S; Häring J; Inwald EC; Moehle C; Ortmann O; Treeck O
BMC Cancer; 2016 Dec; 16(1):951. PubMed ID: 28003019
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of endothelin receptor B inhibits the progression of triple-negative breast cancer.
Gu X; Han S; Cui M; Xue J; Ai L; Sun L; Zhu X; Wang Y; Liu C
Ann N Y Acad Sci; 2019 Jul; 1448(1):5-18. PubMed ID: 30900271
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA ZEB2-AS1 promotes the proliferation, metastasis and epithelial mesenchymal transition in triple-negative breast cancer by epigenetically activating ZEB2.
Zhang G; Li H; Sun R; Li P; Yang Z; Liu Y; Wang Z; Yang Y; Yin C
J Cell Mol Med; 2019 May; 23(5):3271-3279. PubMed ID: 30825262
[TBL] [Abstract][Full Text] [Related]
9. Aberrant methylation of WD-repeat protein 41 contributes to tumour progression in triple-negative breast cancer.
Wang H; Wu D; Cai L; Li X; Zhang Z; Chen S
J Cell Mol Med; 2020 Jun; 24(12):6869-6882. PubMed ID: 32394588
[TBL] [Abstract][Full Text] [Related]
10. MYC and DNMT3A-mediated DNA methylation represses microRNA-200b in triple negative breast cancer.
Pang Y; Liu J; Li X; Xiao G; Wang H; Yang G; Li Y; Tang SC; Qin S; Du N; Zhang H; Liu D; Sun X; Ren H
J Cell Mol Med; 2018 Dec; 22(12):6262-6274. PubMed ID: 30324719
[TBL] [Abstract][Full Text] [Related]
11. The frequency of CpG and non-CpG methylation of Notch3 gene promoter determines its expression levels in breast cancer cells.
Xiao W; Liu X; Niu X; Li C; Guo Y; Tan J; Xiong W; Fan L; Li Y
Exp Cell Res; 2020 Jan; 386(2):111743. PubMed ID: 31770532
[TBL] [Abstract][Full Text] [Related]
12. S-Adenosylmethionine Inhibits Cell Growth and Migration of Triple Negative Breast Cancer Cells through Upregulating MiRNA-34c and MiRNA-449a.
Coppola A; Ilisso CP; Stellavato A; Schiraldi C; Caraglia M; Mosca L; Cacciapuoti G; Porcelli M
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396625
[TBL] [Abstract][Full Text] [Related]
13. Isochlorogenic Acid C Reverses Epithelial-Mesenchymal Transition
Yu JK; Yue CH; Pan YR; Chiu YW; Liu JY; Lin KI; Lee CJ
Anticancer Res; 2018 Apr; 38(4):2127-2135. PubMed ID: 29599331
[TBL] [Abstract][Full Text] [Related]
14. δEF1 associates with DNMT1 and maintains DNA methylation of the E-cadherin promoter in breast cancer cells.
Fukagawa A; Ishii H; Miyazawa K; Saitoh M
Cancer Med; 2015 Jan; 4(1):125-35. PubMed ID: 25315069
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic Inactivation of BRCA1 Through Promoter Hypermethylation and Its Clinical Importance in Triple-Negative Breast Cancer.
Yamashita N; Tokunaga E; Kitao H; Hitchins M; Inoue Y; Tanaka K; Hisamatsu Y; Taketani K; Akiyoshi S; Okada S; Oda Y; Saeki H; Oki E; Maehara Y
Clin Breast Cancer; 2015 Dec; 15(6):498-504. PubMed ID: 26195437
[TBL] [Abstract][Full Text] [Related]
16. A high expression ratio of RhoA/RhoB is associated with the migratory and invasive properties of basal-like Breast Tumors.
Privat M; Cavard A; Zekri Y; Ponelle-Chachuat F; Molnar I; Sonnier N; Bignon YJ
Int J Med Sci; 2020; 17(17):2799-2808. PubMed ID: 33162807
[TBL] [Abstract][Full Text] [Related]
17. Cardamonin, a chalcone, inhibits human triple negative breast cancer cell invasiveness by downregulation of Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
Shrivastava S; Jeengar MK; Thummuri D; Koval A; Katanaev VL; Marepally S; Naidu VGM
Biofactors; 2017 Mar; 43(2):152-169. PubMed ID: 27580587
[TBL] [Abstract][Full Text] [Related]
18. [Inhibition of Histone Deacetylases Reverses Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells through a Slug Mediated Mechanism].
Rahimian A; Barati G; Mehrandish R; Mellati AA
Mol Biol (Mosk); 2018; 52(3):474-481. PubMed ID: 29989579
[TBL] [Abstract][Full Text] [Related]
19. Silibinin inhibits migration and invasion of breast cancer MDA-MB-231 cells through induction of mitochondrial fusion.
Si L; Fu J; Liu W; Hayashi T; Nie Y; Mizuno K; Hattori S; Fujisaki H; Onodera S; Ikejima T
Mol Cell Biochem; 2020 Jan; 463(1-2):189-201. PubMed ID: 31612353
[TBL] [Abstract][Full Text] [Related]
20. miR-638 mediated regulation of BRCA1 affects DNA repair and sensitivity to UV and cisplatin in triple-negative breast cancer.
Tan X; Peng J; Fu Y; An S; Rezaei K; Tabbara S; Teal CB; Man YG; Brem RF; Fu SW
Breast Cancer Res; 2014 Sep; 16(5):435. PubMed ID: 25228385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
